Exosens : Nine-month sales up by almost half

(CercleFinance.com) - Exosens reports a strong rise in sales of 47.
4% to 274.4 million euros, for the first nine months of 2024, due to sustained organic growth (+33.1%) and the successful integration of targeted 2023 acquisitions.

The company also boasts an adjusted gross margin of 132.8 million, an improvement of 4.9 points to 48.4%, driven by growth in sales volumes, improved yields and a favorable product mix.

Given its performance since the start of the year, the specialist in critical amplification, detection and imaging technologies says it is 'perfectly in line with the 2024 objectives communicated at the time of the IPO'.

Copyright (c) 2024 CercleFinance.com. All rights reserved.